| Fluorinated nucleosides as an important class of anticancer and antiviral agents A Cavaliere, KC Probst, AD Westwell, M Slusarczyk Future medicinal chemistry 9 (15), 1809-1833, 2017 | 91 | 2017 |
| Alginate Oligosaccharide-Induced Modification of the lasI-lasR and rhlI-rhlR Quorum-Sensing Systems in Pseudomonas aeruginosa AA Jack, S Khan, LC Powell, MF Pritchard, K Beck, H Sadh, L Sutton, ... Antimicrobial Agents and Chemotherapy 62 (5), 10.1128/aac. 02318-17, 2018 | 58 | 2018 |
| Virtual screening, SAR, and discovery of 5‐(indole‐3‐yl)‐2‐[(2‐nitrophenyl) amino][1, 3, 4]‐oxadiazole as a novel Bcl‐2 inhibitor NI Ziedan, R Hamdy, A Cavaliere, M Kourti, F Prencipe, A Brancale, ... Chemical biology & drug design 90 (1), 147-155, 2017 | 39 | 2017 |
| Development of [89Zr]ZrDFO-amivantamab bispecific to EGFR and c-MET for PET imaging of triple-negative breast cancer A Cavaliere, S Sun, S Lee, J Bodner, Z Li, Y Huang, SM Moores, ... European Journal of Nuclear Medicine and Molecular Imaging, 2020 | 29 | 2020 |
| Preclinical advances in theranostics for the different molecular subtypes of breast cancer H Fang, A Cavaliere, Z Li, Y Huang, B Marquez-Nostra Frontiers in Pharmacology 12, 627693, 2021 | 15 | 2021 |
| Intrathecal delivery of nanoparticle PARP inhibitor to the cerebrospinal fluid for the treatment of metastatic medulloblastoma M Khang, JH Lee, T Lee, HW Suh, S Lee, A Cavaliere, A Rushing, ... Science translational medicine 15 (720), eadi1617, 2023 | 8 | 2023 |
| [89Zr]ZrDFO-CR011 PET Correlates with Response to Glycoprotein Nonmetastatic Melanoma B–targeted Therapy in Triple-negative Breast Cancer S Lee, A Cavaliere, JD Gallezot, T Keler, SK Michelhaugh, E Belitzky, ... Molecular cancer therapeutics 21 (3), 440-447, 2022 | 7 | 2022 |
| Radiosynthesis of [18F]-Labelled Pro-Nucleotides (ProTides) A Cavaliere, KC Probst, SJ Paisey, C Marshall, AKH Dheere, F Aigbirhio, ... Molecules 25 (3), 704, 2020 | 6 | 2020 |
| ImmunoPET imaging identifies the optimal timepoint for combination therapy in xenograft models of triple-negative breast cancer Z Li, E Belitzky, O Blaha, A Cavaliere, SR Katz, M Aboian, L Melegari, ... Cancers 15 (5), 1589, 2023 | 4 | 2023 |
| Determining Binding Affinity (KD) of Radiolabeled Antibodies to Immobilized Antigens E Belitzky, A Cavaliere, K Rajabimoghadam, B Marquez-Nostra Journal of Visualized Experiments (JoVE), e63927, 2022 | 3 | 2022 |
| PET imaging of activated T cells in pancreatic tumors with [18F] F-AraG A Cavaliere, G Foster, MQ Zheng, Z Li, H Huang, J Levi, N Joshi, ... Journal of Nuclear Medicine 62 (supplement 1), 1281-1281, 2021 | 1 | 2021 |
| Radiochemical synthesis of 18F-radiolabelled ProTides for Positron Emission Tomography A Cavaliere Cardiff University, 2018 | 1 | 2018 |
| Pilot PET study of vaginally administered bioadhesive nanoparticles in cynomolgus monkeys: Kinetics and safety evaluation MK Grun, P Honhar, Y Wang, S Rossano, M Khang, HW Suh, K Fowles, ... Bioengineering & Translational Medicine 9 (5), e10661, 2024 | | 2024 |
| Investigation of cell surface murine CD68 as a pan-macrophage biomarker by immunoSPECT and optical imaging B Roohani, S Katz, E Belitzky, A Cavaliere, S Lee, K Rajabimoghadam, ... Nuclear Medicine and Biology 126, 108651, 2023 | | 2023 |
| Development of [111In] In-CHX-A”-DTPA-αCD68 as a SPECT Agent for Non-Invasive Tracking of Macrophages In Vivo E Belitzky, A Cavaliere, S Katz, M Liu, K Rajabimoghadam, ... Journal of Nuclear Medicine 63 (supplement 2), 2869-2869, 2022 | | 2022 |